{"id":"W3030423882","doi":"10.1200/jco.2020.38.15_suppl.tps2579","title":"GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Clinical endpoint; Glioblastoma; Drug development; Investigational Drugs; Phases of clinical research; Agile software development; Oncology; Drug; Internal medicine; Pharmacology; Cancer research; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003293578,0.001662046,0.001103775,0.000616785,0.0003613519,0.0009248265,0.0008060914,0.001073755,0.003666822],"category_scores_gemma":[0.002039087,0.0003402501,0.00162785,0.0004926008,0.001153806,0.001104104,0.001098374,0.003178799,0.0007542702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00101381,"about_ca_system_score_gemma":0.002176608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009009728,"about_ca_topic_score_gemma":0.002379026,"domain_scores_codex":[0.9992039,0.0004574256,0.00003202143,0.0001101159,0.00008855054,0.0001080769],"domain_scores_gemma":[0.9990162,0.0001781584,0.0002305308,0.00007663915,0.00007283205,0.0004255293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5608947,0.03137121,0.008319521,0.002770772,0.003627561,0.0004586027,0.0005752962,0.008659191,0.01614073,0.003734636,0.05247476,0.3109729],"study_design_scores_gemma":[0.7015108,0.254683,0.01068789,0.0004708878,0.001135426,0.0005853638,0.0001981088,0.004774419,0.00337711,0.003886364,0.01860961,0.00008096793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9430431,0.01002477,0.00706665,0.005722543,0.000918948,0.01305902,0.007309185,0.0009338753,0.01192185],"genre_scores_gemma":[0.9312211,0.005373527,0.01888019,0.009840364,0.0004943859,0.01606047,0.01055669,0.0002678326,0.00730532],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.003666822,"threshold_uncertainty_score":0.01741827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.458397954280614,"score_gpt":0.5956186525679424,"score_spread":0.1372206982873284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}